8Margolis DJ,Crombleholme T,Herlyn M.Clinical protocol:Phase Ⅰ trial to evaluate the safety of H5.020CMV.PDGF-B for the treatment of a diabetic insensate foot ulcer.Wound Repair Regen 2000；8(6):480-93.
9Lobmann R,Lehnert H.Strategies for control of diabetic foot syndrome.Amputation rate can be reduced.MMW Fortschr Med 2002；144(18):40-4.
10Middlemas A,Delcroix JD,Sayers NM,et al Enhanced activation of axonally transported stress-activated protein kinases in peripheral nerve in diabetic neuropathy is prevented by neurotrophin-3.Brain 2003；.126 (Pt 7):1671-82.
